UIM9:XETRA:XETRA-UBS ETF SICAV - MSCI Canada UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 38.16

Change

0.00 (0.00)%

Market Cap

N/A

Volume

8.42K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-13 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JARI:XETRA Amundi Index Solutions - Amund..

+1.44 (+3.51%)

USD 100.65B
EUNL:XETRA iShares Core MSCI World UCITS ..

+2.41 (+2.75%)

USD 84.07B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

+0.76 (+3.64%)

USD 79.79B
AW15:XETRA UBS (Irl) ETF plc - MSCI Japan..

+0.46 (+3.89%)

USD 58.88B
FJPR:XETRA Fidelity Sustainable Research ..

+0.17 (+3.51%)

USD 44.90B
EXX7:XETRA iShares Nikkei 225 UCITS ETF (..

+0.72 (+3.50%)

USD 28.25B
SPYL:XETRA SPDR S&P 500 UCITS ETF USD Acc..

+0.31 (+2.76%)

USD 23.49B
PPFB:XETRA iShares Physical Gold ETC EUR

-0.63 (-1.14%)

USD 20.66B
XDEE:XETRA Xtrackers S&P 500 Equal Weight..

+0.31 (+3.36%)

USD 12.74B
EUN5:XETRA iShares Core Corporate Bond UC..

+0.30 (+0.25%)

USD 12.26B

ETFs Containing UIM9:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -11.02% 39% F 38% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -11.02% 42% F 40% F
Trailing 12 Months  
Capital Gain -1.71% 58% F 58% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -1.71% 60% D- 59% D-
Trailing 5 Years  
Capital Gain 60.61% 68% D+ 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 60.61% 69% C- 67% D+
Average Annual (5 Year Horizon)  
Capital Gain 11.64% 71% C- 70% C-
Dividend Return 12.58% 74% C 72% C
Total Return 0.93% 67% D+ 46% F
Risk Return Profile  
Volatility (Standard Deviation) 14.55% 37% F 49% F
Risk Adjusted Return 86.44% 74% C 78% C+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.